Research Study Number:
Principal Investigator:
4952
M. Juliana McElrath, MD, PhD - Member, FHCRC Clinical Research/Professor of Medicine, UW
The overall aim of our studies is to evaluate vaccines for safety and the ability to stimulate immune responses in participants. The ideal vaccine for global use should demonstrate proven safety in HIV negative volunteers, tolerability, and confer protection against HIV. Our studies seek to find an affordable vaccine with the potential for mass production in order to meet global needs.
Time commitment will vary depending on the study.
Volunteers must be:
Both males and females are eligible to participate.
Other eligibility criteria may apply depending on the study.
Persons with 1 or more of the following:
Other eligibility criteria may apply depending on the study.
FHCRC/UW HIV Vaccine Trials Unit
Cabrini Medical Tower
901 Boren, Suite 1320
(corner of Boren & Madison)
Seattle, Washington
For directions and more information please visit: www.seattlevaccines.org
National Institutes of Health (NIH)
$25 for participation in screening. If enrolled in a vaccine trial, volunteers will receive additional compensation for each completed visit.
Open
Kim Louis, HIV Vaccine Trials Unit
(206) 667-2300
HIV, Infectious Disease, Vaccine Studies